FMC Corporation heads into its April 30 Q1 earnings call with a notable divergence: short sellers have been covering aggressively, yet the stock keeps falling.
Short interest tells the most striking story into this print. At 10.3% of free float, the short position is still meaningful — but it has dropped 12% over the past week and 17% over the past month, a sharp unwinding that reflects covering rather than fresh conviction. The borrow market reinforces that picture: cost to borrow is running at just 0.47%, and availability is loose, with the lending pool well below its 52-week peak utilization of nearly 25%. Short sellers are retreating, but the stock — down 7% over the past month to $14.65, with a further 4% drop on April 29 alone — has not rewarded them for doing so.
Options traders are not rushing to hedge into the release. The put/call ratio is at 0.46, actually a touch below its 20-day average of 0.48, and running well off the 52-week high of 0.95. That is closer to the complacent end of the past year's range than the defensive end. The combination of short covering and a low PCR would normally suggest positioning that leans bullish — yet the price action tells the opposite story, which sharpens the question of what the market is actually waiting to hear.
Analyst sentiment has shifted constructively in the run-up. Goldman Sachs raised its target to $21 earlier this month, maintaining a Buy rating, while Wells Fargo and RBC both lifted targets to $17 and $16 respectively — all three moves coming within the last three weeks. The mean price target of $17.59 implies roughly 20% upside from current levels. Bulls, per the Benzinga case, point to management's confidence in a second-half EBITDA recovery toward ~$600 million, with Latin America seasonal tailwinds and improving U.S. volume trends. Bears counter with a more structural concern: FMC absorbed a 9% year-over-year price decline in Q1, driven by intensified competition in Brazil, and guided below consensus for Q2 — a sequence that has already punished the shares twice in recent quarters. The prior two earnings prints saw the stock fall 5.8% and 13.1% on the day respectively, so the market's skittishness heading into this release has precedent.
The factor backdrop is mixed. The dividend score ranks in the 96th percentile, but the EPS surprise rank sits at just the 1st percentile, and 90-day EPS momentum is near the bottom of the universe at the 11th percentile. The EV/EBITDA multiple of 7.8x has drifted lower over the past month. Today's print is ultimately a test of whether FMC's volume recovery in Latin America and the U.S. is materialising fast enough to justify the analyst community's newly raised targets — or whether the second-quarter guidance pattern that has repeatedly disappointed investors is set to repeat.
See the live data behind this article on ORTEX.
Open FMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
